Articles

BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?
BRAF Signaling Inhibition in Glioblastoma:…
by
0 comments
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
p53 Antibodies as a Diagnostic…
by
0 comments
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial
Clinical, Radiometabolic and Immunologic Effects…
by
0 comments
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
Anthracyclines Strike Back: Rediscovering Non-Pegylated…
by
0 comments
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature
Tumor Type Agnostic Therapy Carrying…
by
0 comments
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
Role of the IGF-1 Axis…
by
0 comments
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Endocrine-Based Treatments in Clinically-Relevant Subgroups…
by
0 comments
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Targeting Aberrant FGFR Signaling to…
by
0 comments
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Early Changes of the Standardized…
by
0 comments
Abemaciclib: current role for treating patients with MBC
Abemaciclib: current role for treating…
by
0 comments
Immune system and angiogenesis‑related potential surrogate biomarkers of response to everolimus‑based treatment in hormone receptor‑positive breast cancer: an exploratory study
Immune system and angiogenesis‑related potential…
by
0 comments
Seroconversion in patients with cancer and oncology healthcare workers infected by SARS4 CoV-2
Seroconversion in patients with cancer…
by
0 comments